DK447287D0 - Gaerpromotor, vektor indeholdende en saadan promotor, gaer transformeret med en saadan vektor og fremgangsmaade til fremstilling af et peptid eller protein ved hjaelp af en saadan gaer - Google Patents

Gaerpromotor, vektor indeholdende en saadan promotor, gaer transformeret med en saadan vektor og fremgangsmaade til fremstilling af et peptid eller protein ved hjaelp af en saadan gaer

Info

Publication number
DK447287D0
DK447287D0 DK447287A DK447287A DK447287D0 DK 447287 D0 DK447287 D0 DK 447287D0 DK 447287 A DK447287 A DK 447287A DK 447287 A DK447287 A DK 447287A DK 447287 D0 DK447287 D0 DK 447287D0
Authority
DK
Denmark
Prior art keywords
promotor
vector
activation sequence
upstream activation
peptide
Prior art date
Application number
DK447287A
Other languages
English (en)
Other versions
DK447287A (da
DK173186B1 (da
Inventor
Susan Mary Kingsman
Diana Joan Cousens
Mark Julian Wilson
Edward Hinchliffe
Original Assignee
Delta Biotechnology Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Delta Biotechnology Ltd filed Critical Delta Biotechnology Ltd
Publication of DK447287D0 publication Critical patent/DK447287D0/da
Publication of DK447287A publication Critical patent/DK447287A/da
Application granted granted Critical
Publication of DK173186B1 publication Critical patent/DK173186B1/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/80—Vectors or expression systems specially adapted for eukaryotic hosts for fungi
    • C12N15/81—Vectors or expression systems specially adapted for eukaryotic hosts for fungi for yeasts
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/76—Albumins
    • C07K14/765—Serum albumin, e.g. HSA

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Mycology (AREA)
  • Biotechnology (AREA)
  • Biophysics (AREA)
  • Wood Science & Technology (AREA)
  • Molecular Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Biomedical Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Plant Pathology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Microbiology (AREA)
  • Toxicology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
DK198704472A 1986-08-29 1987-08-27 Gærpromotor, vektor indeholdende en sådan promotor, gær transformeret med en sådan vektor og fremgangsmåde til fremstilling DK173186B1 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB868620926A GB8620926D0 (en) 1986-08-29 1986-08-29 Yeast promoter
GB8620926 1986-08-29

Publications (3)

Publication Number Publication Date
DK447287D0 true DK447287D0 (da) 1987-08-27
DK447287A DK447287A (da) 1988-05-20
DK173186B1 DK173186B1 (da) 2000-03-06

Family

ID=10603398

Family Applications (1)

Application Number Title Priority Date Filing Date
DK198704472A DK173186B1 (da) 1986-08-29 1987-08-27 Gærpromotor, vektor indeholdende en sådan promotor, gær transformeret med en sådan vektor og fremgangsmåde til fremstilling

Country Status (13)

Country Link
US (1) US5739007A (da)
EP (1) EP0258067B1 (da)
JP (1) JP2641457B2 (da)
AT (1) ATE87331T1 (da)
AU (1) AU604257B2 (da)
CA (1) CA1291428C (da)
DE (1) DE3784986T2 (da)
DK (1) DK173186B1 (da)
ES (1) ES2054682T3 (da)
FI (1) FI96620C (da)
GB (2) GB8620926D0 (da)
IE (1) IE59986B1 (da)
ZA (1) ZA876447B (da)

Families Citing this family (43)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0245479B1 (en) * 1985-11-13 1993-02-17 Xoma Corporation Shortened phosphoglycerate kinase promoter
GB8725529D0 (en) * 1987-10-30 1987-12-02 Delta Biotechnology Ltd Polypeptides
IL89992A0 (en) * 1988-04-25 1989-12-15 Phillips Petroleum Co Expression of human serum albumin in methylotrophic yeasts
FR2634495B1 (fr) * 1988-07-01 1990-10-26 Chambon Pierre Procede de preparation d'une proteine par des levures utilisant un systeme inductible, vecteurs et souches transformees correspondantes
FR2649991B2 (fr) * 1988-08-05 1994-03-04 Rhone Poulenc Sante Utilisation de derives stables du plasmide pkd1 pour l'expression et la secretion de proteines heterologues dans les levures du genre kluyveromyces
FR2686899B1 (fr) * 1992-01-31 1995-09-01 Rhone Poulenc Rorer Sa Nouveaux polypeptides biologiquement actifs, leur preparation et compositions pharmaceutiques les contenant.
GB9526733D0 (en) 1995-12-30 1996-02-28 Delta Biotechnology Ltd Fusion proteins
GB9712370D0 (en) 1997-06-14 1997-08-13 Aepact Ltd Therapeutic systems
US6926898B2 (en) 2000-04-12 2005-08-09 Human Genome Sciences, Inc. Albumin fusion proteins
US20050100991A1 (en) * 2001-04-12 2005-05-12 Human Genome Sciences, Inc. Albumin fusion proteins
US20050054051A1 (en) * 2001-04-12 2005-03-10 Human Genome Sciences, Inc. Albumin fusion proteins
US7507413B2 (en) * 2001-04-12 2009-03-24 Human Genome Sciences, Inc. Albumin fusion proteins
US7176278B2 (en) 2001-08-30 2007-02-13 Biorexis Technology, Inc. Modified transferrin fusion proteins
WO2003059934A2 (en) 2001-12-21 2003-07-24 Human Genome Sciences, Inc. Albumin fusion proteins
WO2005003296A2 (en) 2003-01-22 2005-01-13 Human Genome Sciences, Inc. Albumin fusion proteins
CA2841097A1 (en) 2001-12-21 2003-07-24 Human Genome Sciences, Inc. Albumin and g-csf fusion proteins
US20060122374A1 (en) 2002-02-07 2006-06-08 Peter Mertins Albumin-fused anti-angiogenesis peptides
GB0217033D0 (en) 2002-07-23 2002-08-28 Delta Biotechnology Ltd Gene and polypeptide sequences
GB0329681D0 (en) 2003-12-23 2004-01-28 Delta Biotechnology Ltd Gene expression technique
US9057061B2 (en) 2003-12-23 2015-06-16 Novozymes Biopharma Dk A/S Gene expression technique
GB0329722D0 (en) 2003-12-23 2004-01-28 Delta Biotechnology Ltd Modified plasmid and use thereof
CA2552590A1 (en) 2004-01-05 2005-07-21 Emd Lexigen Research Center Corp. Interleukin-12 targeted to oncofoetal fibronectin
EP2330200B1 (en) 2004-12-23 2017-04-05 Albumedix A/S Gene expression technique
WO2006138167A1 (en) 2005-06-14 2006-12-28 Merck & Co., Inc. Synthetic gene control region
DK2046826T3 (da) 2006-07-24 2011-10-24 Biorexis Pharmaceutical Corp Exendin-fusionsproteiner
WO2008019368A2 (en) 2006-08-07 2008-02-14 Teva Biopharmaceuticals Usa, Inc. Albumin-insulin fusion proteins
DK2109457T3 (da) 2007-02-12 2016-04-11 Csl Behring Gmbh Terapeutisk anvendelse af serinprotease-hæmmere af kazal-type
EP2594583A1 (en) 2007-08-08 2013-05-22 Novozymes Biopharma DK A/S Transferrin variants and conugates
JP2011517410A (ja) * 2008-04-08 2011-06-09 アミリス バイオテクノロジーズ， インコーポレイテッド 異種配列の発現
US20110294988A1 (en) 2009-02-06 2011-12-01 Novozymes Bio Pharma DK A/S Purification Process
SG172789A1 (en) 2009-02-11 2011-08-29 Novozymes Biopharma Dk As Albumin variants and conjugates
EP2371857A1 (en) 2010-04-01 2011-10-05 CSL Behring GmbH Factor XII inhibitors for treating interstitial lung disease
AU2012222833B2 (en) 2011-03-03 2017-03-16 Zymeworks Inc. Multivalent heteromultimer scaffold design and constructs
IN2015DN01115A (da) 2012-07-13 2015-06-26 Zymeworks Inc
US10239951B2 (en) 2013-05-08 2019-03-26 Zymeworks Inc. Bispecific HER2 and HER3 antigen binding constructs
CA2874083C (en) 2014-12-05 2024-01-02 Universite Laval Tdp-43-binding polypeptides useful for the treatment of neurodegenerative diseases
EP3394265A1 (en) 2015-12-23 2018-10-31 Biogen MA Inc. Dkk2 cysteine rich domain 2 containing proteins and uses thereof
MA54070A (fr) 2018-10-29 2021-09-08 Biogen Ma Inc Variants fc5 humanisés et stabilisés pour l'amélioration du transport à travers la barrière hémato-encéphalique
US12629445B2 (en) 2020-03-20 2026-05-19 Bard Peripheral Vascular, Inc. Reactive hydrogel forming formulations and related methods, including methods of preparation
CN113462686B (zh) * 2020-03-30 2023-06-02 中国科学院深圳先进技术研究院 制备具有梯度活性的半乳糖诱导合成启动子的方法、及其制备的启动子、应用
US11739166B2 (en) 2020-07-02 2023-08-29 Davol Inc. Reactive polysaccharide-based hemostatic agent
US12161777B2 (en) 2020-07-02 2024-12-10 Davol Inc. Flowable hemostatic suspension
WO2022146917A1 (en) 2020-12-28 2022-07-07 Davol Inc. Reactive dry powdered hemostatic materials comprising a protein and a multifunctionalized modified polyethylene glycol based crosslinking agent

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK368882A (da) * 1981-08-25 1983-02-26 Alan John Kingsman Expessions vektorer
US4803164A (en) * 1981-08-31 1989-02-07 Genentech, Inc. Preparation of hepatitis b surface antigen in yeast
US4876197A (en) * 1983-02-22 1989-10-24 Chiron Corporation Eukaryotic regulatable transcription
GB8314961D0 (en) * 1983-05-31 1983-07-06 Kingsman A J Dna sequence
EP0480480A3 (en) * 1984-05-11 1992-06-10 Chiron Corporation Enhanced yeast transcription employing hybrid promoter region constructs
EP0225887B1 (en) * 1985-04-08 1994-06-08 Amgen Inc. A method and a hybrid promoter for controlling exogenous gene transcription
GB8510219D0 (en) * 1985-04-22 1985-05-30 Bass Plc Isolation of fermentation products
GB8521496D0 (en) * 1985-08-29 1985-10-02 Ciba Geigy Ag Repressible yeast promoters
MY101203A (en) * 1985-12-12 1991-08-17 Ucp Gen Pharma Ag Production of thrombin iinhibitors.

Also Published As

Publication number Publication date
ZA876447B (en) 1988-05-25
ATE87331T1 (de) 1993-04-15
DK447287A (da) 1988-05-20
DE3784986T2 (de) 1993-07-01
FI873729L (fi) 1988-03-01
US5739007A (en) 1998-04-14
FI96620C (fi) 1996-07-25
FI873729A0 (fi) 1987-08-27
JP2641457B2 (ja) 1997-08-13
AU7765787A (en) 1988-05-19
GB2196635A (en) 1988-05-05
DK173186B1 (da) 2000-03-06
JPS63112988A (ja) 1988-05-18
IE59986B1 (en) 1994-05-04
EP0258067A2 (en) 1988-03-02
AU604257B2 (en) 1990-12-13
GB2196635B (en) 1990-12-05
GB8620926D0 (en) 1986-10-08
FI96620B (fi) 1996-04-15
CA1291428C (en) 1991-10-29
GB8720396D0 (en) 1987-10-07
EP0258067A3 (en) 1989-05-10
EP0258067B1 (en) 1993-03-24
DE3784986D1 (en) 1993-04-29
ES2054682T3 (es) 1994-08-16
IE872308L (en) 1988-02-29

Similar Documents

Publication Publication Date Title
DK447287A (da) Gaerpromotor, vektor indeholdende en saadan promotor, gaer transformeret med en saadan vektor og fremgangsmaade til fremstilling af et peptid eller protein ved hjaelp af en saadan gaer
ATE196507T1 (de) Verfahren zur herstellung von viralen vektoren von mindestens 20kb durch intermolekulare homologe rekombination in einer prokaryotischen zelle
IE821985L (en) Expression vectors
AU6632496A (en) Cell derived antigen presenting vesicles
EP0251744A3 (en) Process for the genetic modification of yeast
AU8779782A (en) Preparation of hepatitis b surface antigen in yeast
ATE466869T1 (de) Verfahren zur herstellung von immunogenen hla- a2.1-bindenden peptiden
BG60107B2 (bg) Метод за получаване на еукариотен полипептид
DE69114299D1 (de) Verfahren und zusammensetzungen für gentherapie und stärkung des immunsystems.
AU4880093A (en) Retrovirus from the HIV group and its use
EP0992580A3 (en) Immunodominant human T-cell epitopes of Hepatitis C virus
DK547185D0 (da) Vektorer til ekspression af hirudin, transformerede celler og fremgangsmaade til fremstilling af hirudin
AU2445888A (en) Recombinant fowlpox virus, vectors for the expression of heterologous proteins and vaccines for poultry derived from this virus
ES461179A1 (es) Metodo de obtencion de hormonas proteinicas.
IE883545L (en) Peptide structures, immunogens containing them and their uses in the control of fertility
EP0292257A3 (en) Peptides having anf activity
FR2629871B1 (fr) Commande par vecteur de poussee, ameliorant la manoeuvrabilite d'aeronefs propulses par reaction et methode d'utilisation de cette commande
GR3007491T3 (da)
WO1992011370A3 (de) Von proteinen des hepatitis c-virus abgeleitete polypeptide und deren verwendung
DE3852006D1 (de) Expressionsvektor zur regulierbaren expression von fremdgenen in prokaryonten.
GB1532128A (en) Polypeptide obtained from a sea anemone
IL83435A (en) Dna construct for expression of genes in yeast, an expression vector containing it and yeast transformed with said expression vector
DE3173666D1 (en) Process for preparing immunoglobulin suitable for intravenous injection
Hinchliffe et al. Novel products from surplus yeast via recombinant DNA technology.
Khawaja Preferential effect of oestradiol 17βinvivo on the protein synthetic activity of uterine membrane-bound ribosomes

Legal Events

Date Code Title Description
PUP Patent expired